GlucoTec, the parent company of Glytec, LLC, develops and deploys the G+™ Enterprise Edition, a network-based real-time glycemic management system. The system provides individualized dosage recommendations for insulin, glucose and saline by incorporating patient demographics, lab results and risk factors. Its software can be installed locally or operated remotely over the Internet. The company is led by Chairman Dr. Robert E. Fischell. GlucoTec completed an $8.27M Series A financing and intends to use the proceeds to expand its direct U.S. sales force, grow its international presence and advance research and development. No operating metrics were disclosed in the article.

Total raised

$8M

Funding rounds

1

Latest round

Series A

Latest activity

Sep 2011